Peripheral NKT cells in simian immunodeficiency virus-infected macaques

Journal of Virology

Volumn 83, Issue 4, 2009, Pages 1617-1624

  Fernandez, Caroline S ^a   Chan, Angela C ^a   Kyparissoudis, Konstantinos ^a   De Rose, Robert ^a   Godfrey, Dale I ^a   Kent, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE COUNT; MACACA; NATURAL KILLER T CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS LOAD; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CD4 LYMPHOCYTE COUNT; MACACA NEMESTRINA; NATURAL KILLER T-CELLS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

ANIMALIA; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 59649092930     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02138-08     Document Type: Article

References (38)

1. Batten, C. J., R. D. Rose, K. M. Wilson, M. B. Agy, S. Chea, I. Stratov, D. C. Montefiori, and S. J. Kent. 2006. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. AIDS Res. Hum. Retrovir. 22:580-588.
2. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297-336.
3. Berzins, S. P., A. D. Cochrane, D. G. Pellicci, M. J. Smyth, and D. I. Godfrey. 2005. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur. J. Immunol. 35:1399-1407.
4. Cerundolo, V., and M. Salio. 2007. Harnessing NKT cells for therapeutic applications. Curr. Top. Microbiol. Immunol. 314:325-340.
5. Chang, D. H., K. Osman, J. Connolly, A. Kukreja, J. Krasovsky, M. Pack, A. Hutchinson, M. Geller, N. Liu, R. Annable, J. Shay, K. Kirchhoff, N. Nishi, Y. Ando, K. Hayashi, H. Hassoun, R. M. Steinman, and M. V. Dhodapkar. 2005. Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J. Exp. Med. 201:1503-1517.
6. Chen, X., X. Wang, G. S. Besra, and J. E. Gumperz. 2007. Modulation of CD1d-restricted NKT cell responses by CD4. J. Leukoc. Biol. 82:1455-1465.
7. Coquet, J. M., S. Chakravarti, K. Kyparissoudis, F. W. McNab, L. A. Pitt, B. S. McKenzie, S. P. Berzins, M. J. Smyth, and D. I. Godfrey. 2008. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4- NK1.1- NKT cell population. Proc. Natl. Acad. Sci. USA 105:11287-11292.
8. Coquet, J. M., K. Kyparissoudis, D. G. Pellicci, G. Besra, S. P. Berzins, M. J. Smyth, and D. I. Godfrey. 2007. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178:2827-2834.
9. Crowe, N. Y., J. M. Coquet, S. P. Berzins, K. Kyparissoudis, R. Keating, D. G. Pellicci, Y. Hayakawa, D. I. Godfrey, and M. J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202:1279-1288.
10. Crowe, N. Y., M. J. Smyth, and D. I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene- induced sarcomas. J. Exp. Med. 196:119-127.
11. Dale, C. J., R. De Rose, I. Stratov, S. Chea, D. Montefiori, S. A. Thomson, I. A. Ramshaw, B. E. Coupar, D. B. Boyle, M. Law, and S. J. Kent. 2004. Efficacy of DNA and fowlpoxvirus prime/boost vaccines for simian/human immunodeficiency virus. J. Virol. 78:13819-13828.
12. De Rose, R., C. J. Batten, M. Z. Smith, C. S. Fernandez, V. Peut, S. Thomson, I. A. Ramshaw, B. E. Coupar, D. B. Boyle, V. Venturi, M. P. Davenport, and S. J. Kent. 2007. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. J. Virol. 81:292-300.
13. De Rose, R., C. S. Fernandez, L. Loh, V. Peut, R. D. Mason, S. Alcantara, J. Reece, and S. J. Kent. 2008. Delivery of immunotherapy with peptide-pulsed blood in macaques. Virology 187:204-210.
14. Gansuvd, B., J. Goodwin, C. K. Asiedu, X. L. Jiang, U. Jargal, P. Andrades, M. A. Exley, and J. M. Thomas. 2008. Invariant natural killer T cells from rhesus macaque spleen and peripheral blood are phenotypically and functionally distinct populations. J. Med. Primatol. 37:1-11.
15. Gansuvd, B., W. J. Hubbard, A. Hutchings, F. T. Thomas, J. Goodwin, S. B. Wilson, M. A. Exley, and J. M. Thomas. 2003. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells. J. Immunol. 171:2904-2911.
16. Godfrey, D. I., and S. P. Berzins. 2007. Control points in NKT-cell development. Nat. Rev. Immunol. 7:505-518.
17. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Investig. 114:1379- 1388.
18. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4:231-237.
19. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625-636.
20. Kashiwase, K., A. Kikuchi, Y. Ando, A. Nicol, S. A. Porcelli, K. Tokunaga, M. Omine, M. Satake, T. Juji, M. Nieda, and Y. Koezuka. 2003. The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques. Immunogenetics 54:776-781.
21. Kent, S. J., R. De Rose, V. V. Mokhonov, E. A. Mohkonova, C. S. Fernandez, S. Alcantara, E. Rollman, R. D. Mason, L. Loh, V. Peut, J. Reece, X. J. Wang, K. M. Wilson, A. Suhrbier, and A. A. Khromykh. 2008. Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques. Virology 374:528-534.
22. Lackner, A. A., and R. S. Veazey. 2007. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu. Rev. Med. 58:461-476.
23. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195:637-641.
24. Mason, R. D., R. De Rose, N. Seddiki, A. Kelleher, and S. J. Kent. 2008. Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques. Virology 381:11-15.
25. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
26. Montoya, C. J., J. C. Catano, Z. Ramirez, M. T. Rugeles, S. B. Wilson, and A. L. Landay. 2008. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin. Immunol. 127:1-6.
27. Motsinger, A., A. Azimzadeh, A. K. Stanic, R. P. Johnson, L. Van Kaer, S. Joyce, and D. Unutmaz. 2003. Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells. J. Virol. 77:8153-8158.
28. Motsinger, A., D. W. Haas, A. K. Stanic, L. Van Kaer, S. Joyce, and D. Unutmaz. 2002. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195:869-879.
29. Nowicki, M. J., C. Vigen, W. J. Mack, E. Seaberg, A. Landay, K. Anastos, M. Young, H. Minkoff, R. Greenblatt, and A. M. Levine. 2008. Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res. Hum. Retrovir. 24:163-168.
30. O'Brien, W. A., P. M. Hartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, M. S. Simberkoff, J. D. Hamilton, et al. 1996. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
31. + Vα24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 76:7528-7534.
32. Smith, M. Z., T. E. Asher, V. Venturi, M. P. Davenport, D. C. Douek, D. A. Price, and S. J. Kent. 2008. Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge. J. Virol. 82:7357-7368.
33. Smith, M. Z., C. J. Dale, R. De Rose, I. Stratov, C. S. Fernandez, A. G. Brooks, J. T. Weinfurter, K. Krebs, C. Riek, D. I. Watkins, D. H. O'Connor, and S. J. Kent. 2005. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol. 79:684-695.
34. van der Vliet, H. J., M. G. van Vonderen, J. W. Molling, H. J. Bontkes, M. Reijm, P. Reiss, M. A. van Agtmael, S. A. Danner, A. J. van den Eertwegh, B. M. von Blomberg, and R. J. Scheper. 2006. Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. J. Immunol. 177:5775-5778.
35. van der Vliet, H. J., B. M. von Blomberg, M. D. Hazenberg, N. Nishi, S. A. Otto, B. H. van Benthem, M. Prins, F. A. Claessen, A. J. van den Eertwegh, G. Giaccone, F. Miedema, R. J. Scheper, and H. M. Pinedo. 2002. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J. Immunol. 168:1490-1495.
36. Van Kaer, L. 2007. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19:354-364.
37. Vasan, S., M. A. Poles, A. Horowitz, E. E. Siladji, M. Markowitz, and M. Tsuji. 2007. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection. Int. Immunol. 19:943-951.
38. Watkins, D. I., D. R. Burton, E. G. Kallas, J. P. Moore, and W. C. Koff. 2008. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14:617-621.